About Us

Clinical Microbiology and Infectious Diseases Society of Nigeria.

Clinical Microbiology and Infectious Diseases Society of Nigeria (CLIMIDSON) was registered with the Corporate Affairs Commission in Abuja, Nigeria on March 8, 2010, as an Incorporated Trustee, with registration number CAC/IT/NO 37576. The main objective of the society is the promotion of clinical microbiology practice through education and training, continuing professional development, research, conferences and workshops, and networking with other stakeholders at local and international levels.

The membership of the society cuts across all segments of clinical microbiology and infectious diseases, and related disciplines such as epidemiology, medical statistics, infection control and prevention, surgery, critical medicine and such other disciplines and persons that have an interest in infections and associated matters. Specifically, members are mainly Fellows in Clinical Microbiology, infectious diseases, and other medical specialists, as well as non-medical specialists or non-medical doctors in related professions. Companies and organisms whose activities or products and services are in the fields of infectious diseases and clinical microbiology are also welcome as members

Members of the society are mostly university teachers and practitioners of clinical microbiology and managers of infectious diseases in our teaching and specialist hospital and have been involved in the control of infectious disease outbreaks, including but re not limited to Ebola, and Lassa fever. Cholera, meningitis, and more recently covid-19.

The society is currently spearheading the introduction, practice, and institutionalization of antimicrobial stewardship in Nigeria. It is currently developing a national guidance document for antimicrobial stewardship practice in healthcare facilities in Nigeria.

CLIMIDSON welcomes any form of support and collaboration with individuals, organizations, and governments. The society presently has Dr Kenneth C. Iregbu as its President.